8 Result(s)

Article

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study

Upadacitinib, a Janus kinase inhibitor, has demonstrated efficacy and an acceptable safety profile in patients with ankylosing spondylitis (AS) in the phase III SELECT-AXIS programs. We report the 1-year effic...

Xenofon Baraliakos, Désirée van der Heijde, Joachim Sieper… in Arthritis Research & Therapy (2023)

Article

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis

Patients with ankylosing spondylitis (AS) have significant unmet treatment needs, despite advancements in biologic therapies. This study evaluated the impact of upadacitinib on clinically meaningful improvemen...

Victoria Navarro-Compán, Xenofon Baraliakos, Marina Magrey… in Rheumatology and Therapy (2023)

Article

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies

The objective of this post-hoc analysis was to assess the efficacy and safety of upadacitinib in psoriatic arthritis (PsA) patients with axial involvement.

Xenofon Baraliakos, Roberto Ranza, Andrew Östör… in Arthritis Research & Therapy (2023)

Article

Radiosynthesis and characterization of [¹⁸F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism

Translocator protein 18-kDa (TSPO) positron emission tomography (PET) is a valuable tool to detect neuroinflammed areas in a broad spectrum of neurodegenerative diseases. However, the clinical application of s...

Sang Hee Lee, Nunzio Denora… in European Journal of Nuclear Medicine and M… (2021)

Article

Erratum to: Correlation of electrode position and clinical outcomes in Globus pallidus stimulation for dystonia

Hye Ran Park, Jae Min Lee, Gwanhee Ehm, Hui-Jun Yang, In Ho Song… in Acta Neurochirurgica (2017)

Article

Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockers

The aim of this study was to investigate the influence of symptom duration on treatment response and on the correlation between improvements in patient reported outcomes (PRO) and objective inflammation in pat...

Anja Weiß, In-Ho Song, Hildrun Haibel, Joachim Listing… in Arthritis Research & Therapy (2014)